TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Mankind Pharma Ltd.

MANKIND on NSE · 19 Nov 2026

NIFTY 500 F&O

2,629.00 ▲ +0.15 % on the day

Overview Technical Risk & rank Results Accounts Filings Options Guidance & governance

Balance sheet

What the company owns and owes, as reported.

₹ cr30 Sep 202631 Mar 202630 Sep 202531 Mar 202530 Sep 202431 Mar 2024
Total assets28,95428,08028,81327,76013,98211,963
Equity attributable to owners17,58216,30015,28614,33210,5659,363
Current borrowings2,3203,4194,1602,971455175
Non-current borrowings3,1012,8934,2085,5402733
Cash and cash equivalents1,114392328407727382

Cash flow

Where the cash came from and went, by financial year.

₹ crYear to Mar 2026Year to Mar 2025Year to Mar 2024Year to Mar 2023
Cash flow from operating activities3,1212,4132,1521,813
Cash flow from investing activities-196-12,683-2,082-1,054
Cash flow from financing activities-2,95310,2905-740
Purchase of property, plant and equipment626461315789

Figures are consolidated, in ₹ cr unless the line is a percentage, from the company's results filed with NSE. Companies report a balance sheet twice a year and cash flow for the year to date; a dash means the line was not reported.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in